Tolerability of Selective Serotonin Reuptake Inhibitors
- 1 January 2008
- journal article
- research article
- Published by Springer Nature in Drugs & Aging
- Vol. 25 (6), 501-519
- https://doi.org/10.2165/00002512-200825060-00004
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- The Clinical Pharmacokinetics of EscitalopramClinical Pharmacokinetics, 2007
- Outpatient Medications and Hip Fractures in the USDrugs & Aging, 2005
- Severe Adverse Drug Reactions of Antidepressants: Results of the German Multicenter Drug Surveillance Program AMSPPharmacopsychiatry, 2004
- Selective serotonin-reuptake inhibitor antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channelsMedical Hypotheses, 2001
- Adverse Reactions of Selective Serotonin Reuptake InhibitorsDrug Safety, 1999
- Selective Serotonin Reuptake Inhibitors in Older PatientsDrugs & Aging, 1997
- Clinically Relevant Pharmacology of Selective Serotonin Reuptake InhibitorsClinical Pharmacokinetics, 1997
- Recent Advances in Geriatric PsychopharmacologyDrugs & Aging, 1995
- Pharmacological Differences of Serotonin Reuptake Inhibitors and Possible Clinical RelevanceDrugs, 1992
- A double‐blind comparison of citalopram (Lu 10–171) and amitriptyline in depressed patientsActa Psychiatrica Scandinavica, 1987